Picture of PROCEPT BioRobotics logo

PRCT — PROCEPT BioRobotics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

Procept Biorobotics Corp Reports Results For The Quarter Ended In December: Earnings Summary

* PROCEPT BioRobotics Corp  PRCT.OQ  reported a quarterly
adjusted
loss of 56 cents​​ per share for the quarter ended in December.
The mean expectation of seven analysts for the quarter was for a
loss of 54 cents per share.
    * Revenue rose 134.5% to $23.78 million from a year ago;
analysts
expected $23.01 million. 
    * PROCEPT BioRobotics Corp's reported EPS for the quarter
was a
loss of 63 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.7%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * PROCEPT BioRobotics Corp shares had fallen by 10.1% this
quarter.
    * The company reported a quarterly loss of $28.17 million.
    * Wall Street's median 12-month price target for PROCEPT
BioRobotics Corp is $52.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
28 at 10:55 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.54          -0.56          Missed
 Sep. 30 2022      -0.48          -0.51          Missed
 Jun. 30 2022      -0.48          -0.43          Beat
 Mar. 31 2022      -0.47          -0.39          Beat

Recent news on PROCEPT BioRobotics

See all news